🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07782450
Treatments Being Tested
A Phase Ia/Ib open label，clinical study evaluating the safety, tolerability...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2023-06-29
Trial ID
NCT05868876
Treatments Being Tested
Hepatorenal syndrome (HRS) is a common cause of acute kidney injury (AKI) i...
Status
Unknown
Location
University of Virginia Health System
Start Date
2013-02
Trial ID
NCT02147470
Treatments Being Tested
This is a a Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation a...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-02-03
Trial ID
NCT04178460
Treatments Being Tested
Comparison of the Effectiveness of Behavioral Therapy, Maxillary Lip Bumper...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-02
Trial ID
NCT06650241
Treatments Being Tested
Rapid maxillary expansion (RME) is a commonly used orthodontic treatment in...
Status
Completed
Location
Multiple Locations
Start Date
2016-07-01
Trial ID
NCT04604392
Treatments Being Tested
Part I was a double-blind, randomized, vehicle-controlled Proof of Concept ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00961896
Treatments Being Tested
This is an open-label, multicenter, dose-escalation and expansion Phase Ib ...
Status
Completed
Location
UCLA Cancer Center
Start Date
2016-01-07
Trial ID
NCT02650713
Treatments Being Tested